期刊文献+

CYP17 T27C polymorphism and prostate cancer risk: a meta-analysis based on 31 studies

CYP17 T27C polymorphism and prostate cancer risk: a meta-analysis based on 31 studies
下载PDF
导出
摘要 Objective:The cytochrome P450 17α-hydroxylase(CYP17)plays a vital role in androgen biosynthesis.A T-to-C polymorphism in the 5'promoter region of CYP17 has been implicated as a risk factor for prostate cancer,but the results of individual studies are inconclusive or controversial.To derive a more precise estimation of the relationship,we performed an updated meta-analysis from 31 studies based on 27 publications.Methods:A comprehensive search was conducted to examine all the eligible studies of CYP17 polymorphism and prostate cancer risk.We used odds ratios(ORs)with 95%confidence intervals(CIs)to assess the strength of the association.Results:Overall,individuals with CC/CT genotype were not associated with prostate cancer risk (CC vs.TT:OR=1.03,95%CI=0.86-1.24,P=0.72,P heterogeneity 〈0.0001;CT vs.TT:OR=0.99,95%CI=0.87- 1.12,P=0.88,P heterogeneity =0.0006).In the stratified analysis by ethnicity,there was a significantly increased risk of prostate cancer among individuals of African descent under the recessive model(OR=1.56,95%CI=1.01- 2.39,P=0.04,P heterogeneity =0.65).Conclusion:This meta-analysis suggested that CYP17 polymorphism might be associated with prostate cancer risk among individuals of African descent. Objective:The cytochrome P450 17α-hydroxylase(CYP17)plays a vital role in androgen biosynthesis.A T-to-C polymorphism in the 5'promoter region of CYP17 has been implicated as a risk factor for prostate cancer,but the results of individual studies are inconclusive or controversial.To derive a more precise estimation of the relationship,we performed an updated meta-analysis from 31 studies based on 27 publications.Methods:A comprehensive search was conducted to examine all the eligible studies of CYP17 polymorphism and prostate cancer risk.We used odds ratios(ORs)with 95%confidence intervals(CIs)to assess the strength of the association.Results:Overall,individuals with CC/CT genotype were not associated with prostate cancer risk (CC vs.TT:OR=1.03,95%CI=0.86-1.24,P=0.72,P heterogeneity 〈0.0001;CT vs.TT:OR=0.99,95%CI=0.87- 1.12,P=0.88,P heterogeneity =0.0006).In the stratified analysis by ethnicity,there was a significantly increased risk of prostate cancer among individuals of African descent under the recessive model(OR=1.56,95%CI=1.01- 2.39,P=0.04,P heterogeneity =0.65).Conclusion:This meta-analysis suggested that CYP17 polymorphism might be associated with prostate cancer risk among individuals of African descent.
出处 《The Journal of Biomedical Research》 CAS 2010年第3期233-241,共9页 生物医学研究杂志(英文版)
关键词 CYP17 prostate cancer META-ANALYSIS CYP17, prostate cancer, meta-analysis
  • 相关文献

参考文献10

  • 1Carey A H,Waterworth D,Patel K,et al.Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17[].Human Molecular Genetics.1994
  • 2Woolf B.On estimating the relation between blood group and disease[].Annals of Human Genetics.1955
  • 3Lau J,Ioannidis JP,Schmid CH.Quantitative synthesis in systematic reviews[].Annals of Internal Medicine.1997
  • 4VW Setiawan,FR Schumacher,CA Haiman,DO Stram,D Albanes,D Altshuler.CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)[].Cancer Epidemiology Biomarkers and Prevention.2007
  • 5Halabi,S.,Small,E.J.,Kantoff,P.W.Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer[].Journal of Clinical Oncology.2003
  • 6Ntais,C,Polycarpou,A,Ioannidis,JP.Association of the CYP17 gene polymorphism with the risk of prostate cancer: a meta-analysis[].Cancer Epidemiology Biomarkers and Prevention.2003
  • 7S Lindstrom,F Wiklund,HO Adami,KA Balter,J Adolfsson,H Gronberg.Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development[].Cancer Research.2006
  • 8Lindstrom,S.,Zheng,S. L.,Wiklund,F.,Jonsson,B. A.,Adami,H. O.,Balter,K. A.Systematic replication study of reported genetic associations in prostate cancer: Strong support for genetic variation in the androgen pathway[].Prostate.2006
  • 9Wadelius,M,Andersson,AO,Johansson,JE,Wadelius,C,Rane,E.Prostate cancer associated with CYP17 genotype[].Pharmacogenetics.1999
  • 10Lunn,RM,Bell,DA,Mohler,JL,Taylor,JA.Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2)[].Carcinogenesis.1999

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部